Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
58.82
+0.76 (1.31%)
At close: Aug 14, 2026, 4:00 PM EDT
58.94
+0.12 (0.21%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $4.31 billion as of August 14, 2026. Its market cap has increased by 264.06% in one year.
Market Cap
4.31B
Enterprise Value
3.42B
1-Year Change
264.06%
Ranking
Category
Stock Price
$58.82
ChartMarket Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $4.31B, an increase of 342.47%. That is a compound annual growth rate of 53.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 4.31B | 371.56% |
| Dec 31, 2025 | 913.95M | -16.86% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
| Feb 24, 2023 | 974.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Edgewise Therapeutics | 4.80B |
| Parabilis Medicines | 4.72B |
| Veradermics | 4.71B |
| Celcuity | 4.50B |
| Relay Therapeutics | 4.35B |
| Tango Therapeutics | 4.32B |
| Telix Pharmaceuticals | 4.03B |
| Legend Biotech | 3.94B |